Paul W. Hoelscher - Jun 5, 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:05 PM
Previous filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Award $0 +9.28K $0.00 9.28K Jun 5, 2024 Series A Common Stock 9.28K $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date.